Antitumorigenic effects of cannabinoids beyond apoptosis.
about
Cannabinoids as therapeutic agents in cancer: current status and future implicationsMonoacylglycerol lipase - a target for drug development?The molecular connections between the cannabinoid system and endometriosisKetoconazole inhibits the cellular uptake of anandamide via inhibition of FAAH at pharmacologically relevant concentrationsAppraisals of Bangladeshi Medicinal Plants Used by Folk Medicine Practitioners in the Prevention and Management of Malignant Neoplastic DiseasesPotential upstream regulators of cannabinoid receptor 1 signaling in prostate cancer: a Bayesian network analysis of data from a tissue microarray.Fatty acid amide hydrolase in prostate cancer: association with disease severity and outcome, CB1 receptor expression and regulation by IL-4Tumour Cannabinoid CB(1) receptor and phosphorylated epidermal growth factor receptor expression are additive prognostic markers for prostate cancer.High tumour cannabinoid CB1 receptor immunoreactivity negatively impacts disease-specific survival in stage II microsatellite stable colorectal cancer.Endocannabinoid involvement in endometriosis.Cannabidiol as potential anticancer drug.The Antitumor Activity of Plant-Derived Non-Psychoactive Cannabinoids.Association between cannabinoid CB₁ receptor expression and Akt signalling in prostate cancer.Cannabinoid receptor type 1 (CB1) activation inhibits small GTPase RhoA activity and regulates motility of prostate carcinoma cells.Cannabidiol inhibits angiogenesis by multiple mechanisms.A Double Whammy: Targeting Both Fatty Acid Amide Hydrolase (FAAH) and Cyclooxygenase (COX) To Treat Pain and Inflammation.Population-based case-control study of recreational drug use and testis cancer risk confirms an association between marijuana use and nonseminoma riskLipid mediators involved in the oxidative stress and antioxidant defence of human lung cancer cells.Delta(9) -tetrahydrocannabinol and cannabidiol as potential curative agents for cancer: A critical examination of the preclinical literature.The evolving role of the endocannabinoid system in gynaecological cancer.The Clinical Significance of Endocannabinoids in Endometriosis Pain Management.Antitumorigenic targets of cannabinoids - current status and implications.Expression and functionality of TRPV1 receptor in human MCF-7 and canine CF.41 cells.Cannabinoid receptor-2 agonist inhibits macrophage induced EMT in non-small cell lung cancer by downregulation of EGFR pathway.Standardized Cannabis sativa extract attenuates tau and stathmin gene expression in the melanoma cell line.
P2860
Q26866298-407233B2-D6FC-4973-96B1-C18167032984Q26998964-D7E0F6DC-5107-45E0-96C2-A2126C8F34C1Q27005719-3A3D31A3-7B5D-48A9-8436-FF88F54FA369Q28539116-76244119-992A-49E3-97B2-D3D3C4D66582Q28828586-E3F86920-47F6-47DD-B420-C5DDB10AB14CQ30830112-B58F24ED-2273-4A4A-B71B-5D4058493F48Q33680523-829BB46B-F8D4-4C13-9CDB-0FC163897976Q33784488-7ACD52F0-9417-43B1-97A5-F9B25E5FFF4FQ34013690-B3B556A9-CDDC-4F79-AA7D-1A678D3EDF4FQ34274062-14A93FE4-8A5C-4379-B989-D14BBC162DDDQ34637516-518E44F7-E326-442F-8030-C68FB2504B6BQ34669534-90F9C5F3-A5C8-4C57-9781-D32E5AA64AFBQ34766747-C0B6B911-B478-434D-AB05-DE8D5CB8EBDAQ35646098-73A8840F-5AA6-4589-91A6-EE8373415265Q36419293-83F3B99C-D24D-49CC-A1F7-25848CCB4BDAQ36823364-1FFAEE30-E1E9-4AC4-A354-29FF74CAAF74Q37178515-A79FB0FC-8695-400A-AF2F-5B9AF219E620Q37223268-9846944D-2E0E-47F5-B262-80594730D958Q38351132-20ABEA9D-95AA-4F8B-8727-40DC27695E1EQ38469671-012B1CC7-0CF5-4468-BBA5-8559D444C6CFQ38598498-10B4B304-93E6-4FC9-B6A7-08F23F98D5E0Q38806270-67721420-9DDD-446B-B5BA-A9C2A59513FDQ39178517-73811394-94EC-47D0-A2FF-166F60C5806AQ40133231-CE5949CF-CD39-4402-B1E2-2D43BC220AE2Q47164822-2378504F-7198-47B9-A0AE-5F3A4E2A4624
P2860
Antitumorigenic effects of cannabinoids beyond apoptosis.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Antitumorigenic effects of cannabinoids beyond apoptosis.
@en
Antitumorigenic effects of cannabinoids beyond apoptosis.
@nl
type
label
Antitumorigenic effects of cannabinoids beyond apoptosis.
@en
Antitumorigenic effects of cannabinoids beyond apoptosis.
@nl
prefLabel
Antitumorigenic effects of cannabinoids beyond apoptosis.
@en
Antitumorigenic effects of cannabinoids beyond apoptosis.
@nl
P2093
P356
P1476
Antitumorigenic effects of cannabinoids beyond apoptosis.
@en
P2093
Burkhard Hinz
Nadine Freimuth
Robert Ramer
P304
P356
10.1124/JPET.109.157735
P407
P577
2009-11-04T00:00:00Z